In our study, GNAS mutations were detected in 41.5% of the pure pancreatic juice and in 66.7% of the resected tissue specimens from cases with IPMN; these mutation rates were nearly equal to those in previous reports. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.